Ms. Benedetti, INDUCING PROPERTIES OF RIFABUTIN, AND EFFECTS ON THE PHARMACOKINETICSAND METABOLISM OF CONCOMITANT DRUGS, Pharmacological research, 32(4), 1995, pp. 177-187
Rifabutin, a rifamycin derivative like rifampicin, has been registered
for the treatment of pulmonary tuberculosis and for the prophylaxis a
nd treatment of MAC in patients with AIDS. Rifabutin induces cytochrom
e P-450 3A4. The effect of rifabutin on the pharmacokinetics and metab
olism of drugs administered concomitantly to humans (isoniazid, ethamb
utol, zidovudine, didanosine, delavirdine, fluconazole, itraconazole,
methadone, clarithromycin, theophylline and cyclosporin) has been revi
ewed. (C) 1995 The Italian Pharmacological Society